Johnson & Johnson stock falls despite strong earnings as investors focus on medtech unit
Johnson & Johnson stock is tumbling even after the healthcare giant raised its forecast again for full-year earnings and revenue.
Johnson & Johnson stock is tumbling even after the healthcare giant raised its forecast again for full-year earnings and revenue.
What's Your Reaction?
